FindTrial
Sign In

A Survey to Assess the Impact of the COVID-19 Pandemic and Resultant Lockdown Measures on Ongoing Clinical Trials in India

A Survey to Assess the Impact of the COVID-19 Pandemic and Resultant Lockdown Measures on Ongoing Clinical Trials in India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027420
Enrollment
130
Registered
2020-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Jayanti Gupta
Lead Sponsor
Rakesh Dadhania
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Principal investigators and site research staff of ongoing clinical trials Ethics Committee members of sites with ongoing clinical trials

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Responses to study questionnaires by PI/site research staffTimepoint: baseline—

Secondary

MeasureTime frame
Responses to study questionnaires by EC memberTimepoint: baseline—

Countries

India

Contacts

Public ContactRakesh Dadhania

NishKash Consulting

jayantigupta@nishkash.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 15, 2026